Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+6.68%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$17.7B
AUM Growth
+$1.64B
Cap. Flow
+$822M
Cap. Flow %
4.64%
Top 10 Hldgs %
32.89%
Holding
1,376
New
56
Increased
735
Reduced
284
Closed
54

Sector Composition

1 Real Estate 45.9%
2 Technology 16.73%
3 Consumer Discretionary 5.58%
4 Communication Services 5.5%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RLAY icon
1201
Relay Therapeutics
RLAY
$705M
$4K ﹤0.01%
486
SAGE
1202
DELISTED
Sage Therapeutics
SAGE
$4K ﹤0.01%
239
SPRY icon
1203
ARS Pharmaceuticals
SPRY
$1.04B
$4K ﹤0.01%
367
SRRK icon
1204
Scholar Rock
SRRK
$3.13B
$4K ﹤0.01%
208
TARS icon
1205
Tarsus Pharmaceuticals
TARS
$2.42B
$4K ﹤0.01%
107
VRNA
1206
Verona Pharma
VRNA
$9.2B
$4K ﹤0.01%
244
DCPH
1207
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
272
AUTL
1208
Autolus Therapeutics
AUTL
$389M
$4K ﹤0.01%
575
BCRX icon
1209
BioCryst Pharmaceuticals
BCRX
$1.75B
$4K ﹤0.01%
692
ARCT icon
1210
Arcturus Therapeutics
ARCT
$473M
$3K ﹤0.01%
90
AUPH icon
1211
Aurinia Pharmaceuticals
AUPH
$1.66B
$3K ﹤0.01%
528
BCYC
1212
Bicycle Therapeutics
BCYC
$494M
$3K ﹤0.01%
103
BNS icon
1213
Scotiabank
BNS
$79.4B
$3K ﹤0.01%
50
CABA icon
1214
Cabaletta Bio
CABA
$145M
$3K ﹤0.01%
175
ELVN icon
1215
Enliven Therapeutics
ELVN
$1.22B
$3K ﹤0.01%
+152
New +$3K
GRFS icon
1216
Grifois
GRFS
$6.88B
$3K ﹤0.01%
398
HCM icon
1217
HUTCHMED
HCM
$2.73B
$3K ﹤0.01%
185
KNSA icon
1218
Kiniksa Pharmaceuticals
KNSA
$2.63B
$3K ﹤0.01%
139
MGNX icon
1219
MacroGenics
MGNX
$131M
$3K ﹤0.01%
209
OABI icon
1220
OmniAb
OABI
$232M
$3K ﹤0.01%
475
YMAB icon
1221
Y-mAbs Therapeutics
YMAB
$389M
$3K ﹤0.01%
+162
New +$3K
ZLAB icon
1222
Zai Lab
ZLAB
$3.44B
$3K ﹤0.01%
193
ZNTL icon
1223
Zentalis Pharmaceuticals
ZNTL
$128M
$3K ﹤0.01%
212
ZYME icon
1224
Zymeworks
ZYME
$1.08B
$3K ﹤0.01%
286
OLMA icon
1225
Olema Pharmaceuticals
OLMA
$467M
$3K ﹤0.01%
224